Stefanie Morgan, PhD
Stanford cancer-biology PhD leading AgelessRx clinical trials, including PEARL rapamycin and GLP-1 studies
Practice
About
Stefanie Morgan, PhD trained in cancer biology and genetics at Stanford University School of Medicine, completed postdoctoral work at Harvard Medical School, and worked as a research fellow at Massachusetts General Hospital before moving into biotech leadership. She joined AgelessRx in 2024 as Vice President of Operations and Applied Science, where she helps lead the company's research program. Her AgelessRx work includes corresponding-author involvement on the PEARL low-dose rapamycin trial and principal-investigator roles on registered studies of combination gerotherapeutics and alternative GLP-1 administration.
Approach
Signature approach
Morgan's work sits upstream of prescribing. She focuses on trial design, molecular-biology context, data analysis, and study operations that shape which interventions AgelessRx investigates and how results feed back into the platform. That makes her profile most relevant to users evaluating the scientific backbone behind AgelessRx, especially rapamycin, GLP-1, and combination-longevity research.
What sets them apart
- PEARL trial role. Morgan was a corresponding author on AgelessRx's published low-dose rapamycin study in healthy adults.
- Registered trial leadership. She is listed as principal investigator on ClinicalTrials.gov studies for combination gerotherapeutics and alternative GLP-1 administration.
- Bench-to-platform training. Stanford cancer biology, Harvard postdoctoral work, MGH cancer research, Cellino, and Watershed Informatics give her a molecular and trial-operations base uncommon inside consumer telehealth.
Focus
Specialties
Training
Education
- PhD, Cancer Biology and GeneticsStanford University School of Medicine
- Postdoctoral FellowshipHarvard Medical School
- Bachelor of ScienceBridgewater State University
Fellowship
- Postdoctoral fellowshipHarvard Medical School
Protocols
- Clinical trial design
- Molecular biology
- Genomics
- Bioinformatics
Published work
Publications
- Aging (Albany NY), 2025
- PubMed Central, 2018
- Aging, 2025
- GeroScience, 2025
- Cureus, 2025
Elsewhere
Media and talks
- Aging-US
- BioSpace · 2025-02-05
- ScienceBlog.com
- Aging
- TimeWarp Labs · 2026-08
- ARDD 2026 · 2026-10
Profiles
Verification
- Profile updated
Primary sourcehttps://agelessrx.com/about-us
Where a detail is missing, it means we have not verified it—not that the answer is no. Directory listings are for informational purposes only. Inclusion does not constitute endorsement. Verify credentials and qualifications independently.